Allena Pharmaceuticals, Inc. Non-current Liabilities (Other)

Non-current Liabilities (Other) of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-current Liabilities (Other) growth rates and interactive chart.


Highlights and Quick Summary

  • Non-current Liabilities (Other) for the quarter ending June 30, 2021 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Non-current Liabilities (Other) decreased by NaN%
  • Annual Non-current Liabilities (Other) for 2020 was $0 (a -100.0% decrease from previous year)
  • Annual Non-current Liabilities (Other) for 2018 was $30 Thousand (a -90.63% decrease from previous year)
  • Annual Non-current Liabilities (Other) for 2017 was $320 Thousand (a -13.51% decrease from previous year)
Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-current Liabilities (Other) of Allena Pharmaceuticals, Inc.

Most recent Non-current Liabilities (Other)of ALNA including historical data for past 10 years.

Interactive Chart of Non-current Liabilities (Other) of Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Non-current Liabilities (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0
2019 $0.01 $0.02
2018 $0.03 $0.04 $0.01 $0.38 $0.03
2017 $0.32 $0.73 $0.32
2016 $0.37
2015 $0.24 $0.25

Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.